SEC Form D · filed April 1, 2019
INNOVATE BIOPHARMACEUTICALS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Anthony Maida · Raleigh, NCDirectorLorin K. Johnson · Raleigh, NCDirectorSaira K. Ramasastry · Raleigh, NCDirectorSandeep Laumas · Raleigh, NCExec · DirectorRoy K. Proujansky · Raleigh, NCDirectorJay Madan · Raleigh, NJExec · DirectorArnar Agnarsson · Bozeman, MTDirectorRuan Van Vuuren · Grand Cayman, Cayman IslandsDirectorJeffrey Myers · New York, NYDirectorRyan Belanger-Saleh · New York, NYDirectorScott Zeilinger · New York, NYExec · DirectorKevin Cavenaugh · Portland, ORExec · DirectorWilliam P. Corry · Sewickley, PADirectorChristopher Long · Mission Woods, KSDirectorShinji Kim · SAN FRANCISCO, CADirectorCampbell Congdon · Grand Cayman, Cayman IslandsDirectorJay Madan · Raleigh, NJExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗